|
TXNDC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.623900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.528420E-01 |
| Normal-vs-Stage2 |
2.880000E-03 |
| Normal-vs-Stage3 |
1.299190E-03 |
| Normal-vs-Stage4 |
1.336810E-03 |
| Stage1-vs-Stage2 |
2.588300E-02 |
| Stage1-vs-Stage3 |
1.202140E-02 |
| Stage1-vs-Stage4 |
1.278340E-02 |
| Stage2-vs-Stage3 |
8.913200E-01 |
| Stage2-vs-Stage4 |
7.106800E-01 |
| Stage3-vs-Stage4 |
8.089400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.751500E-02 |
| Normal-vs-AfricanAmerican |
5.775100E-03 |
| Normal-vs-Asian |
1.800190E-01 |
| Caucasian-vs-AfricanAmerican |
8.747900E-02 |
| Caucasian-vs-Asian |
9.261000E-01 |
| AfricanAmerican-vs-Asian |
2.157000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.417800E-03 |
| Normal-vs-Female |
2.406400E-02 |
| Male-vs-Female |
3.447600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.698010E-01 |
| Normal-vs-Age(41-60Yrs) |
1.281920E-02 |
| Normal-vs-Age(61-80Yrs) |
3.842900E-03 |
| Normal-vs-Age(81-100Yrs) |
9.459600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.412610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.019900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.587200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.371000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.351200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.370250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.998100E-02 |
| Classical-VS-Follicular |
7.804000E-02 |
| Classical-VS-Other |
1.145180E-01 |
| Classical-VS-Normal |
3.317700E-02 |
| Tall-VS-Follicular |
5.465200E-01 |
| Tall-VS-Other |
7.598600E-01 |
| Tall-VS-Normal |
6.647300E-04 |
| Follicular-VS-Other |
6.074000E-01 |
| Follicular-VS-Normal |
1.356310E-03 |
| Other-VS-Normal |
4.695700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.691640E-02 |
| Normal-vs-N1 |
2.444800E-03 |
| N0-vs-N1 |
1.834240E-01 |
|
|
